Harshad R. Kulkarni, MD is Chief Medical Advisor at BAMF Health Theranostics Center in Grand Rapids and Clinical Associate Professor of Radiology at the Michigan State University College of Human Medicine. He is nuclear medicine physician with vast clinical, research and teaching experience from Germany in theranostic oncology, specialising in molecular imaging, dosimetry and targeted alpha- and beta-emitting radiopharmaceutical therapy of prostate cancer, and neuroendocrine neoplasms, as well as Theranostics for thyroid diseases. He has been lead investigator of several major radiopharmaceutical clinical trials, including first-in-human studies with novel radiopharmaceutical targeting.

The speaker discloses the following relationships:
• Employment with BAMF Health.
• Receipt of an honorarium from GE Healthcare.
• Service on advisory boards for Novartis and GE Healthcare.
• Participation in speakers' bureaus for United Imaging and ITM.
• Recipient of a funded grant from United Imaging.